AKWZESQAFBESGD-RUZDIDTESA-N
C25H30N2O6S2 — CID 135903311
Data last refreshed: (MolForge compound catalog, from PubChem)
About AKWZESQAFBESGD-RUZDIDTESA-N
AKWZESQAFBESGD-RUZDIDTESA-N (PubChem CID 135903311) has the molecular formula C25H30N2O6S2 and a molecular weight of 518.66 g/mol. Its IUPAC name is (1R)-1-(3,3-dimethylbutyl)-4-hydroxy-3-[7-(methoxymethoxymethyl)-1,1-dioxo-4H-thieno[2,3-e][1,2,4]thiadiazin-3-yl]-1-methylnaphthalen-2-one.
Molecular Properties
| Compound Name | AKWZESQAFBESGD-RUZDIDTESA-N |
|---|---|
| PubChem CID | 135903311 |
| Molecular Formula | C25H30N2O6S2 |
| Molecular Weight | 518.66 g/mol |
| Exact Mass | 518.15 |
| IUPAC Name | (1R)-1-(3,3-dimethylbutyl)-4-hydroxy-3-[7-(methoxymethoxymethyl)-1,1-dioxo-4H-thieno[2,3-e][1,2,4]thiadiazin-3-yl]-1-methylnaphthalen-2-one |
| SMILES | COCOCc1csc2c1S(=O)(=O)N=C(C1=C(O)c3ccccc3[C@@](C)(CCC(C)(C)C)C1=O)N2 |
| InChI | InChI=1S/C25H30N2O6S2/c1-24(2,3)10-11-25(4)17-9-7-6-8-16(17)19(28)18(21(25)29)22-26-23-20(35(30,31)27-22)15(13-34-23)12-33-14-32-5/h6-9,13,28H,10-12,14H2,1-5H3,(H,26,27)/t25-/m1/s1 |
| InChIKey | AKWZESQAFBESGD-RUZDIDTESA-N |
| XLogP | 5.02 |
| TPSA | 114.29 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 518.66 |
| LogP ≤ 5 | 5.02 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 135903311 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.